Pet FTM Project

Bruno (on the cover) is a half-breed foundling dog belonging to one of EuBiome's shareholders; he fell ill with chronic enteropathy at the age of 5. A long journey has begun in search of solutions to his monthly crisis of diarrhea and vomiting. After years of never resolving attempts Bruno underwent a fecal microbiome transplant and today he is fine. We would like the same opportunity to be available to others who, like him, can benefit from this treatment.We are aware that FMT is only in its infancy, that attempts are being made and that the results are mixed. But the results are there, to testify that it is necessary to continue to research, to understand why it sometimes works and sometimes it doesn't, to understand what and how much material to administer, and when. Isn't it true that partial, temporary results and failures also occur with standard protocols? Special diets, probiotics, antibiotics and immunosuppressants. FMT risks have been extensively evaluated in humans, and the most frequent sentence in literature is that "FMT is safe". The risks are considered irrelevant compared to the benefits that can be obtained; and consider that dogs and cats are often coprophages. Further proof is the fact that there are over 400 FMT clinical trial .
The Pet FMT Project was  born with the aim of aggregating people passionate of dogs, cats and microbiome, to accelerate the development of knowledge on FMT and help to transform successful cases into clinical protocols, and to offer a therapeutic option for the 30 million of dogs and cats suffering from chronic enteropathy in Europe.